Preferred Name |
danicopan |
Synonyms |
ACH-0144471 |
ID |
http://purl.bioontology.org/ontology/MESH/C000718467 |
altLabel |
ACH-0144471 ACH-4471 (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide |
cui |
C5139702 C4724880 |
HM |
D011743 D000631 D007191 D011392 |
Inverse of RB |
0 JM8C1SFX0U |
Mapped to |
http://purl.bioontology.org/ontology/MESH/D000631 http://purl.bioontology.org/ontology/MESH/D011392 |
MDA |
20210730 |
MeSH Frequency |
2 |
MMR |
20210730 |
notation |
C000718467 |
prefLabel |
danicopan |
SC |
1 |
Scope Statement |
complement factor D inhibitor |
SRC |
Curr Med Chem. 2020;27(25):4165-4180. |
TERMUI |
T001109353 T001109356 T001109354 T001109355 |
TH |
NLM (2021) FDA SRS (2017) USAN (19XX) INN (19XX) |
tui |
T109 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C148181 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |